: iStockAnalyst.com Symbols Feed

Analyst Comments: Juniper, Anaren, Microsemi, Akamai, Akzo Nobel, Nabors, Banco Santander

Tue, 09 Sep 2008 16:00:00 GMT

Juniper Networks, Inc. (JNPR) is enjoying robust growth in its infrastructure business as service providers are spending on next generation networks. Although results have been good, we are growing increasingly concerned about levels of capital spending by service providers in light of indications that spending could be slowing. In light of this, we maintain a Hold recommendation on the shares of JNPR. Shares of JNPR are currently trading at a P/E multiple of 24.4x our 2008 earnings estimate of $0.99. Juniper has raised its long-term revenue growth target to 27.1% (at the mid-point of the new guidance) after posting 23.1% revenue growth in 2007. We lower our price target to $25.50, which represents a P/E multiple of 25.8x 2008 earnings estimates. Juniper's net margin has been on a declining trend due to a considerable increase in its[More...]

Analyst Comments: PLATO, Akzo Nobel, American Public, El Paso, Alexion

Tue, 08 Jul 2008 19:50:00 GMT

We maintain Hold rating on the shares of PLATO Learning, Inc. (TUTR). Though the company's cost-cutting initiatives and new product pipeline are encouraging, the transition from a licensed-based to a subscription-based model for its products and services[More...]

Analyst Comments: Akzo Nobel, Canon, Interactive Data, Amag Pharmaceuticals, Enterprise Products

Wed, 30 Apr 2008 14:21:24 GMT

Akzo Nobel N.V. (AKZOY) is enhancing its global position in coatings through acquisitions and internal growth. The company sold its pharma business to Schering-Plough Corporation (SGP). Thus, Akzo Nobel is a core chemicals and coatings company.[More...]

Analyst Comments: Stryker, BJ's Wholesale, Fannie Mae, Dean Foods, CombinatoRx, Akzo Nobel, AmBev, Aftermarket, American Capital, Overseas Shipholding, Joy Global, Stone Energy, Dollar Financial, Santarus

Fri, 07 Mar 2008 22:47:20 GMT

In February 2008, Stryker Corporation (SYK) announced a $750 million share buyback program that reflects its strong cash position, offsetting some share dilution while also suggesting lack of solid acquisition targets. Stryker's strength is its diversification. Core hips and knees are about one-third of total revenues, making Stryker the least directly exposed to the reconstructive implant market of any of the major orthopedic manufacturers,...[More...]

Acquisition Issues with Akzo Nobel

Mon, 10 Dec 2007 15:55:28 GMT

An update has come out on Akzo Nobel N.V. (AKZOY), in which senior chemical industry analyst Paul Raman, CFA is reiterating his Hold rating on the company. We excerpted the following details:'Akzo Nobel is enhancing its global position in coatings through acquisitions and internal growth. The company sold its pharma business to Schering-Plough (SGP)....[More...]

Painted Into A Corner

Tue, 17 Jul 2007 16:16:58 GMT

According to Paint & Coatings Industry, the top three paint manufacturers are Akzo Nobel (AKZOY), PPG Industries (PPG) and Sherwin-Williams (SHW). These stocks have all done well over the last year despite the slowing demand in two of the largest end-markets for paint: housing and autos. [More...]

Flint Hills Job Fair

Thu, 15 Jan 2009 14:47:00 GMT

Jan. 15--It looked like a miniature oil show, complete with goodies for participants and booths with banners featuring company names.
But the 150 representatives from more than 60 companies at the Polydome at Flint Hills Resources Odessa Plant weren't there to sell their products.
They were looking to find workers at the plant, which is scheduled to shut down by May.

[More...]